Live feed
Filing
SC 13G
SC 13G0001104659-21-090669·LENZ Therapeutics, Inc.
Schedule 13G ownership disclosure
GRAPHITE BIO INC
Security class unavailable · CUSIP: 38870X104
Event date: 2021-06-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,393,870
- Percent of class
- 12.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-090669
- Form type
- SC 13G
- Filer
- LENZ Therapeutics, Inc.
- CIK
- CIK 1815776
- Filed
- Jul 09, 2021
- Reporting period
- Jun 29, 2021
- Description
- Schedule 13G beneficial ownership